For moderate-to-severe COPD or those with risk factors, baseline cardiac investigations are advised, including 12-lead ECG, echocardiography, fasting lipid profile, fasting glucose/HbA1c, and NT-proBNP measurement. The gene discussed is NPPB; the disease is chronic obstructive pulmonary disease.